MedPath

Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff

Not Applicable
Conditions
Covid-19
Interventions
Other: ivermectin impregnated mask
Registration Number
NCT04723459
Lead Sponsor
South Valley University
Brief Summary

Antiviral efficacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks

Detailed Description

Antiviral effecacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks this study is a trial for evaluation of adding a proved antiviral material to the mask and to compare between the protective value of this mask and the ordinary one.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • health care personells and family contact of confirmed COVID-19 cases.
Exclusion Criteria
  • refusal of participate to use the masks.
  • pregnancy or lactation known hypersensitivity to ivermectin.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ivermectin mask groupivermectin impregnated maskContacts who will use ivermectin masks
Primary Outcome Measures
NameTimeMethod
Number of persons in each group who Complain of any suspected Symptomswithin 14 days after enrollement

( Fever, Myalgia ,Cough, Sore Throat, Diarrhea, Shortness of Breath)

Secondary Outcome Measures
NameTimeMethod
Number of persons in each group who are diagnosed as COVID-19 patientswithin 21 days after enrollement

swab test

Trial Locations

Locations (1)

Zaky Aref

🇪🇬

Qina, Egypt

© Copyright 2025. All Rights Reserved by MedPath